Substance P Modulation of Human and Murine Corneal Neovascularization.
暂无分享,去创建一个
[1] S. Swamynathan,et al. Inhibition of HUVEC tube formation via suppression of NF&kgr;B suggests an anti‐angiogenic role for SLURP1 in the transparent cornea , 2017, Experimental eye research.
[2] P. Rama,et al. Growth inhibition of formed corneal neovascularization following Fosaprepitant treatment , 2017, Acta ophthalmologica.
[3] P. Stuart,et al. Understanding the Role of Chemokines and Cytokines in Experimental Models of Herpes Simplex Keratitis , 2017, Journal of immunology research.
[4] J. F. Gomez-Sosa,et al. Angiogenic mechanisms of human dental pulp and their relationship with substance P expression in response to occlusal trauma , 2017, International endodontic journal.
[5] S. Douglas,et al. Substance P–mediated chemokine production promotes monocyte migration , 2017, Journal of leukocyte biology.
[6] Jiucheng He,et al. Neuroanatomy and Neurochemistry of Mouse Cornea , 2016, Investigative ophthalmology & visual science.
[7] M. Słoniecka,et al. Substance P Enhances Keratocyte Migration and Neutrophil Recruitment through Interleukin-8 , 2016, Molecular Pharmacology.
[8] P. Gascón,et al. Biological and Pharmacological Aspects of the NK1-Receptor , 2015, BioMed research international.
[9] M. Słoniecka,et al. Expression Profiles of Neuropeptides, Neurotransmitters, and Their Receptors in Human Keratocytes In Vitro and In Situ , 2015, PloS one.
[10] J. Niederkorn,et al. Severing Corneal Nerves in One Eye Induces Sympathetic Loss of Immune Privilege and Promotes Rejection of Future Corneal Allografts Placed in Either Eye , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[11] P. Rama,et al. NK1 receptor antagonists as a new treatment for corneal neovascularization. , 2014, Investigative ophthalmology & visual science.
[12] G. Comi,et al. Ocular surface injury induces inflammation in the brain: in vivo and ex vivo evidence of a corneal-trigeminal axis. , 2014, Investigative ophthalmology & visual science.
[13] Lixin Xie,et al. Substance P Promotes Diabetic Corneal Epithelial Wound Healing Through Molecular Mechanisms Mediated via the Neurokinin-1 Receptor , 2014, Diabetes.
[14] T. Chikama,et al. Neuropeptides released from trigeminal neurons promote the stratification of human corneal epithelial cells. , 2014, Investigative ophthalmology & visual science.
[15] P. Hamrah,et al. Corneal Allograft Rejection: Immunopathogenesis to Therapeutics , 2013, Journal of clinical & cellular immunology.
[16] R. Dana,et al. Corneal innervation as a window to peripheral neuropathies. , 2013, Experimental eye research.
[17] K. Maruyama,et al. Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases , 2013, Progress in Retinal and Eye Research.
[18] P. Rama,et al. Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring. , 2013, Investigative ophthalmology & visual science.
[19] L. Coppola,et al. Analysis of nerve supply pattern in human lymphatic vessels of young and old men. , 2012, Lymphatic research and biology.
[20] C. Joo,et al. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. , 2012, Investigative ophthalmology & visual science.
[21] R. Dana,et al. Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin). , 2012, The ocular surface.
[22] R. Channappanavar,et al. Substance P in the corneal stroma regulates the severity of herpetic stromal keratitis lesions. , 2011, Investigative ophthalmology & visual science.
[23] R. Lavker,et al. Limbal fibroblast conditioned media: A non-invasive treatment for limbal stem cell deficiency , 2011, Molecular vision.
[24] D. Zawieja,et al. Substance P Activates Both Contractile and Inflammatory Pathways in Lymphatics Through the Neurokinin Receptors NK1R and NK3R , 2011, Microcirculation.
[25] Dexter L. Lee,et al. Role of IL-6 in angiotensin II-induced retinal vascular inflammation. , 2010, Investigative ophthalmology & visual science.
[26] S. Wiegand,et al. Cutting Edge: Lymphatic Vessels, Not Blood Vessels, Primarily Mediate Immune Rejections After Transplantation , 2009, The Journal of Immunology.
[27] J. Lowe,et al. Architecture and distribution of human corneal nerves , 2009, British Journal of Ophthalmology.
[28] M. Skobe,et al. Blocking the path of lymphatic vessels , 2009, Nature Medicine.
[29] C. Irwin,et al. Neuropeptides regulate expression of angiogenic growth factors in human dental pulp fibroblasts. , 2009, Journal of endodontics.
[30] T. Chikama,et al. Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy , 2008, British Journal of Ophthalmology.
[31] W. Fokkens,et al. Modulation of neurotrophin and neurotrophin receptor expression in nasal mucosa after nasal allergen provocation in allergic rhinitis , 2008, Allergy.
[32] S. Benemei,et al. The concept of neurogenic inflammation , 2008, BJU international.
[33] K. Bartz-Schmidt,et al. Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn , 2007, Acta ophthalmologica.
[34] D. Sellami,et al. Epidemiology and risk factors for corneal graft rejection. , 2007, Transplantation proceedings.
[35] Claus Cursiefen,et al. Immune privilege and angiogenic privilege of the cornea. , 2007, Chemical immunology and allergy.
[36] D. Walsh,et al. Tachykinins and the cardiovascular system. , 2006, Current drug targets.
[37] D. Sanders,et al. The Effect of Combinations of Flurbiprofen, Low Molecular Weight Heparin, and Doxycycline on the Inhibition of Corneal Neovascularization , 2006, Cornea.
[38] B. Seitz,et al. Surgery-related factors influencing corneal neovascularization after low-risk keratoplasty. , 2006, American journal of ophthalmology.
[39] F. Shanahan,et al. The role of substance P in inflammatory disease , 2004, Journal of cellular physiology.
[40] T. Nishida,et al. Effects of substance P and IGF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy. , 2003, Investigative ophthalmology & visual science.
[41] Claus Cursiefen,et al. Corneal Lymphangiogenesis: Evidence, Mechanisms, and Implications for Corneal Transplant Immunology , 2003, Cornea.
[42] Paul H. Black,et al. Stress and the inflammatory response: A review of neurogenic inflammation , 2002, Brain, Behavior, and Immunity.
[43] J. D. Richardson,et al. Cellular Mechanisms of Neurogenic Inflammation , 2002, Journal of Pharmacology and Experimental Therapeutics.
[44] B. Kirchhof,et al. Inhibition of inflammatory corneal angiogenesis by TNP-470. , 2001, Investigative ophthalmology & visual science.
[45] M. T. Tran,et al. Substance P differentially stimulates IL-8 synthesis in human corneal epithelial cells. , 2000, Investigative ophthalmology & visual science.
[46] J. Laissue,et al. Localization of receptors for vasoactive intestinal peptide, somatostatin, and substance P in distinct compartments of human lymphoid organs. , 1998, Blood.
[47] P. Holzer. Implications of Tachykinins and Calcitonin Gene-Related Peptide in Inflammatory Bowel Disease , 1998, Digestion.
[48] C. Murphy,et al. [Neurotrophic keratopathy--studies on substance P and the clinical significance of corneal sensation]. , 1997, Nippon Ganka Gakkai zasshi.
[49] H. Colten,et al. Pulmonary inflammation--a balancing act. , 1997, The New England journal of medicine.
[50] K. Yamada,et al. An examination of the close relationship between lymphatic vessels and nerve fibers containing calcitonin gene-related peptide and substance P in rat skin. , 1996, Nagoya journal of medical science.
[51] N. Frossard,et al. Selective recruitment of eosinophils by substance P after repeated allergen exposure in allergic rhinitis , 1995, Allergy.
[52] C. Belmonte,et al. Neurotrophic influences on corneal epithelial cells. , 1994, Experimental eye research.
[53] C. Murphy,et al. Stimulation of epithelial cell growth by the neuropeptide substance P , 1993, Journal of cellular biochemistry.
[54] S. Nakanishi,et al. The primary structure and gene organization of human substance P and neuromedin K receptors. , 1992, European journal of biochemistry.
[55] M. Moskowitz,et al. Intraneuronal substance P contributes to the severity of experimental arthritis. , 1984, Science.
[56] J. Folkman,et al. Tumor growth and neovascularization: an experimental model using the rabbit cornea. , 1974, Journal of the National Cancer Institute.
[57] C. Pothoulakis,et al. Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease. , 2014, Physiological reviews.
[58] D. Azar. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). , 2006, Transactions of the American Ophthalmological Society.
[59] D. Ganea,et al. Expression of NK-1 receptor mRNA in murine T lymphocytes. , 1996, Neuroimmunomodulation.
[60] J. Foreman. Substance P and calcitonin gene-related peptide: effects on mast cells and in human skin. , 1987, International archives of allergy and applied immunology.